LIAM'S LIGHTHOUSE FOUNDATION
  • Home
  • Get Involved
    • Be The Match
    • Events & Campaigns >
      • Liam's Lighthouse Foundation Annual Golf Tournament
      • 5K to Fight Histio
      • Light The Way Program
    • Subscribe
    • Contact Us
  • About Us
    • Our Mission
    • Do you know Histio? >
      • What is HLH?
      • INTO-HLH
      • Other Histiocytic Disorders
      • Important Links
    • Liam's Story
    • Board Members/Volunteers
  • Donate
    • General Donations

 News 

5K to Fight Histio 2021 - Grants Awarded

7/30/2021

Comments

 
We are pleased to announce that proceeds from our 2021 event will go to help fund the following research initiatives:
​

​HLHRUXO: Use of a Response-Adapted Ruxolitinib-containing Regimen for the Treatment of Hemophagocytic Lymphohistiocytosis run by Dr. Kim Nichols lab at St. Jude Children’s Research Hospital.  This trial is based on our basic laboratory research and aims to test the efficacy of a new type of drug called a JAK inhibitor for children with HLH. JAK inhibitors suppress the pro-inflammatory effects of cytokines, and in so doing, they decrease the manifestations of HLH. Although we have some support from industry, we need more funding in order to complete the trial and carry out studies to better understand whether and how the JAK inhibitor mediates its effects in patients with HLH.  For more details about this trial, please click here:  HLHRUXO Trial

Personalized histiocytosis care with HistioTrak: (run by Dr. Ashish Kumar’s Lab at Cincinnati Children’s Hospital.)  We now know that all histiocytoses are driven by acquired mutations in one of the members of the MAP kinase pathway - most commonly BRAF and MAP2K1.  After development and validation of HistioTrak, a novel molecular testing method to detect rare histiocytic cells in the patient's blood, we will follow the mutation levels in blood while the patient is undergoing treatment. 

If the patient enters molecular remission (i.e. no detectable cells with mutation) using ultrasensitive molecular techniques, it may be safe to stop therapy without risk of relapse.  In order to clinically validate this hypothesis, funds are needed to generate the prospective data on a large patient cohort. This will help develop a personalized clinical treatment algorithm for guiding physicians for their specific patient, with their specific molecular alteration about stopping target therapy without the risk of disease relapse/recurrence.

​
Comments

    NEWS

    Find out what's new at LLF by following our News Blog!

    Register to receive newsletters, grants funded, events information and more right to your email inbox!

    Register Now

    RSS Feed

    Archives

    July 2021
    June 2020
    May 2020
    November 2019
    September 2019
    August 2019
    July 2019
    February 2019
    November 2018
    September 2018
    October 2017
    July 2015
    November 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    January 2014
    July 2013
    May 2013
    September 2012
    July 2012
    August 2011
    April 2011
    September 2010
    August 2010
    June 2010
    May 2010
    April 2010
    March 2010
    January 2010

​light - house, (n): a tower with a powerful light positioned at some important point to serve as a guide.

Find Us At

Subscribe to Emails
Picture

Liam's Lighthouse Foundation  -  5818 Charlois Court | Colorado Springs, CO 80922-2226 USA
 EIN #  27-1309152
The content on this site is not intended to be a substitute for professional medical advice, diagnosis or treatment.
  • Home
  • Get Involved
    • Be The Match
    • Events & Campaigns >
      • Liam's Lighthouse Foundation Annual Golf Tournament
      • 5K to Fight Histio
      • Light The Way Program
    • Subscribe
    • Contact Us
  • About Us
    • Our Mission
    • Do you know Histio? >
      • What is HLH?
      • INTO-HLH
      • Other Histiocytic Disorders
      • Important Links
    • Liam's Story
    • Board Members/Volunteers
  • Donate
    • General Donations